The World Health Organization (WHO) on May 20 approved a pandemic agreement that is aimed at preventing, preparing for, and responding to future health emergencies.
One section outlines how pharmaceutical companies that volunteer will provide the WHO with 20 percent of their vaccines, medicines, and tests. The WHO will then distribute the products “on the basis of public health risk and need, with particular attention to the needs of developing countries.”
The exact process will be laid out in a future agreement that will be considered at the 2026 World Health Assembly.
The consensus vote took place during the assembly on Tuesday, a day after a committee meeting in which 124 countries voted in favor, zero objected, and 11 abstained.
The approval of the agreement followed three years of negotiations.
“The Agreement is a victory for public health, science and multilateral action. It will ensure we, collectively, can better protect the world from future pandemic threats. It is also a recognition by the international community that our citizens, societies and economies must not be left vulnerable to again suffer losses like those endured during COVID-19.”
The treaty builds on the International Health Regulations, which were adopted in 2005 and legally bind countries to take certain actions to prevent and respond to public health problems. China and some other nations have flouted the requirements in the past, including during the COVID-19 pandemic.
The agreement states in part that nothing in it “shall be interpreted as providing the Secretariat of the World Health Organization, including the Director-General of the World Health Organization, any authority to direct, order, alter or otherwise prescribe the national and/or domestic law, as appropriate, or policies of any Party, or to mandate or otherwise impose any requirements that Parties take specific actions, such as ban or accept travellers, impose vaccination mandates or therapeutic or diagnostic measures or implement lockdowns.”